Bionik Laboratories Corp. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bionik Laboratories Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q1 2023.
  • Bionik Laboratories Corp. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $114K, a 42.5% increase year-over-year.
  • Bionik Laboratories Corp. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $300K, a 25% decline year-over-year.
  • Bionik Laboratories Corp. annual Share-based Payment Arrangement, Expense for 2022 was $300K, a 25% decline from 2021.
  • Bionik Laboratories Corp. annual Share-based Payment Arrangement, Expense for 2021 was $400K, a 50% decline from 2020.
  • Bionik Laboratories Corp. annual Share-based Payment Arrangement, Expense for 2020 was $800K, a 52.9% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $300K $114K +$34K +42.5% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-21
Q4 2022 $266K $31K -$169K -84.5% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $435K $55K +$35K +175% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $400K $100K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $400K $80K -$20K -20% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-21
Q4 2021 $420K $200K +$100K +100% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 $320K $20K -$180K -90% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $500K $100K -$300K -75% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $800K $100K -$1.1M -91.7% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-09
Q4 2020 $1.9M $100K -$347K -77.6% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $2.25M $200K +$174K +660% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.07M $400K +$371K +1301% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.7M $1.2M +$1.17M +4042% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-24
Q4 2019 $531K $447K +$412K +1190% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $118K $26.3K -$11K -29.4% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $129K $28.6K -$11.1K -28.1% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $141K $28.9K Jan 1, 2019 Mar 31, 2019 10-K 2020-06-30
Q4 2018 $34.6K Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-11
Q3 2018 $37.3K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $39.7K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.